International Trade Bulletin - Volume 1, Issue 7
Client Alert | 1 min read | 06.12.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CUSTOMS IN THE SPOTLIGHT
- REGULATIONS: Recent Regulations Proposed by Department of State Will Make U.S. Agency Regulators More Accountable for Regulatory Commitments Abroad
- PHARMACEUTICALS: Pharmaceutical Companies May Face Override of Patent Rights for Public Health Concerns
- FREE TRADE AGREEMENTS: Multi-National Firms Use Southeast Asian FTAs to Enter Indian Markets Demonstrating the Benefits of FTAs to Non-FTA Party Companies
- WTO: New Agreement Among WTO Members Could Allow Foreign Companies Greater Access to Taiwan's Government Procurement Market
- ANTI-DUMPING IN THE EU : European Commissioner for Trade, Peter Mandleson, announces review to decide the best way of balancing competing commercial interests in enforcing EU anti-dumping policy
- EXPORT CONTROLS: BIS Reaffirms Deemed Export Rules By Formally Withdrawing Advance Notice of Proposed Rulemaking
- C-TPAT: C-TPAT Establishes Mandatory Security Link Portal
Contacts
Insights
Client Alert | 5 min read | 08.21.26
FTC Proposes Enforcement Policy Statement on Personalized Pricing: What Businesses Need to Know
On August 19, 2026, the Federal Trade Commission (FTC) announced a proposed Enforcement Policy Statement on personalized pricing — the practice of companies using consumers’ personal data to set individualized prices, discounts, coupons, or other incentives. The proposed statement, which is open for public comment for 30 days following publication in the Federal Register, marks a major step up in the FTC’s focus on data-driven pricing strategies and puts businesses across industries on notice that undisclosed or inadequately disclosed personalized pricing will not be tolerated. Importantly, while the proposed statement is not a binding legal requirement and does not create new legal obligations, it serves as an enforcement warning that the FTC is prepared to use its existing enforcement authority under Section 5 of the FTC Act (Section 5) and is also a potential harbinger of rulemaking. Businesses that engage in — or are considering — personalized pricing should carefully assess their disclosure practices and data collection procedures against the standards articulated in this statement.
Client Alert | 7 min read | 08.19.26
CMS’s Final Rule Bans Federal Medicaid Funding for Youth Gender-Affirming Care
Client Alert | 2 min read | 08.19.26


